Sep 13 – 15, 2026
University of Muenster (Castle)
Europe/Berlin timezone

Zoonotic Risk Assessment of 2.3.4.4b H5Nx Avian Influenza-A Viruses Reveals Intermediate Host Systems as Key Determinants of Productive Replication in Primary Human Lung Tissues

Sep 14, 2026, 1:43 PM
1m
Basement

Basement

Poster presentation Epidemiology and emerging viruses Poster viewing

Speaker

Dr Sriram Kumar (Immunology of Respiratory Tract Infections, University Hospital Gießen and Marburg, Germany)

Description

Clade 2.3.4.4b H5Nx highly pathogenic avian influenza viruses (HPAIVs) have diversified extensively during global spread, yet the determinants of their zoonotic potential remain incompletely understood. We characterized eleven genetically distinct H5Nx isolates collected in Germany between 2016 and 2021 using comparative genomics and physiologically relevant human respiratory models. Despite representing multiple reassortant lineages with some substitutions linked to mammalian fitness, none encoded canonical mammalian-adaptive markers PB2-E627K, PB2-D701N, or PB2-Q591K. All isolates replicated efficiently in avian and mammalian cell lines regardless of propagation history. In contrast, primary human lung explants and differentiated nasal epithelial air-liquid interface cultures revealed a propagation-dependent phenotype: Egg-derived viruses exhibited no infectivity, while the same isolates propagated in MDCK cells established productive infection in both upper and lower respiratory tract models. Repropagation in eggs restored the restricted phenotype without adaptive mutations, implying reversible host-dependent factors, potentially including glycosylation-related changes. All viruses exhibited susceptibility to oseltamivir. These findings identify propagation host as a key determinant of 2.3.4.4b H5Nx infectivity in human respiratory tract, highlighting the value of primary human respiratory models for improving zoonotic risk assessment beyond genomic surveillance alone.

Keywords

H5Nx Viruses, Zoonotic Potential, Avian Influenza, Human Lung, ex vivo Infection

Registration ID Inf26-0027
Professional status of the speaker Postdoc
Junior scientist status No, I am not a junior scientist.

Authors

Dr Sriram Kumar (Immunology of Respiratory Tract Infections, University Hospital Gießen and Marburg, Germany) Dr Duygu Merve Çalışkan (Institute of Virology, University Hospital Münster, University of Münster, Germany) Dr Darisuran Anhlan (Institute of Virology, University Hospital Münster, University of Münster, Germany) Ms Anmari Christersson (Institute of Virology, University Hospital Münster, University of Münster, Germany) Dr Saskia Hinse (Immunology of Respiratory Tract Infections, University Hospital Gießen and Marburg, Germany) Ms Pia Madeleine Leipe (Institute of Virology, University Hospital Münster, University of Münster, Germany) Dr Susanne Köthe (Institute of Diagnostic Virology, Friedrich Loeffler Institute, Greifswald, Germany) Ms Vera Krüger (Department of Thoracic Surgery and Lung Support, Ibbenbüren Hospital, Germany) Prof. Stefan Fischer (Department of Thoracic Surgery and Lung Support, Ibbenbüren Hospital, Germany) Prof. Stephan Ludwig (Institute of Virology, University Hospital Münster, University of Münster, Germany) Prof. Timm Harder (Institute of Diagnostic Virology, Friedrich Loeffler Institute, Greifswald, Germany) Prof. Martin Beer (Institute of Diagnostic Virology, Friedrich Loeffler Institute, Greifswald, Germany) Prof. Linda Brunotte (Immunology of Respiratory Tract Infections, University Hospital Gießen and Marburg, Germany)

Presentation materials

There are no materials yet.

External references

Peer reviewing

Paper